CUHK Researchers Proves Low-Concentration Atropine Eye Drops Reducing Myopia Progression in Children with Minimal Side Effects
A CUHK study revealed that children of two parents with high myopia have 12 times the risk of developing myopia. LAMP study principal investigator Dr. Jason YAM (right) hopes the second phase of study can help prevent these children from myopia.
The Faculty of Medicine established that low-concentration atropine eye drops reduce the progression of myopia in school children by up to nearly 70%, with much reduced side effects. As the prevalence of myopia in Hong Kong children aged 6 to 8 ranges from 10% to 41% - the highest in the world - the use of low-concentration atropine drops can supplement an increase in outdoor activities and less near work in preventing or slowing the progression of myopia.
Findings were published in the international journal Ophthalmology.